JP2012529423A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012529423A5 JP2012529423A5 JP2011552249A JP2011552249A JP2012529423A5 JP 2012529423 A5 JP2012529423 A5 JP 2012529423A5 JP 2011552249 A JP2011552249 A JP 2011552249A JP 2011552249 A JP2011552249 A JP 2011552249A JP 2012529423 A5 JP2012529423 A5 JP 2012529423A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- peptide
- modified
- leucine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011552249A JP5688587B2 (ja) | 2009-06-11 | 2010-06-10 | 脈絡膜新血管新生に対するワクチン療法 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009140363 | 2009-06-11 | ||
| JP2009140363 | 2009-06-11 | ||
| PCT/JP2010/003871 WO2010143435A1 (en) | 2009-06-11 | 2010-06-10 | Vaccine therapy for choroidal neovascularization |
| JP2011552249A JP5688587B2 (ja) | 2009-06-11 | 2010-06-10 | 脈絡膜新血管新生に対するワクチン療法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012529423A JP2012529423A (ja) | 2012-11-22 |
| JP2012529423A5 true JP2012529423A5 (enExample) | 2013-07-25 |
| JP5688587B2 JP5688587B2 (ja) | 2015-03-25 |
Family
ID=43308696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011552249A Expired - Fee Related JP5688587B2 (ja) | 2009-06-11 | 2010-06-10 | 脈絡膜新血管新生に対するワクチン療法 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8975229B2 (enExample) |
| EP (1) | EP2440226A4 (enExample) |
| JP (1) | JP5688587B2 (enExample) |
| KR (1) | KR20120038419A (enExample) |
| CN (1) | CN102802654A (enExample) |
| AU (1) | AU2010259797B2 (enExample) |
| BR (1) | BRPI1013025A2 (enExample) |
| CA (1) | CA2764562A1 (enExample) |
| IL (1) | IL216402A0 (enExample) |
| MX (1) | MX2011012659A (enExample) |
| RU (1) | RU2555345C2 (enExample) |
| SG (2) | SG10201403109VA (enExample) |
| TW (1) | TW201109029A (enExample) |
| WO (1) | WO2010143435A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2289532A1 (en) | 2005-02-28 | 2011-03-02 | Oncotherapy Science, Inc. | Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides |
| ES2405763T3 (es) * | 2007-02-16 | 2013-06-03 | Oncotherapy Science, Inc. | Vacunoterapia para la neovascularización coroidea |
| FR2990352A1 (fr) | 2012-05-10 | 2013-11-15 | Univ Paris 13 | Composition immunogene comprenant un peptide derive du vegf et ses utilisations |
| CN110612115A (zh) * | 2017-05-19 | 2019-12-24 | 学校法人庆应义塾 | 针对脑神经疾病的肽疫苗和肽疫苗组合物 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5861301A (en) | 1992-02-20 | 1999-01-19 | American Cayanamid Company | Recombinant kinase insert domain containing receptor and gene encoding same |
| CN1173991C (zh) | 1992-11-13 | 2004-11-03 | 马克斯普朗克科学促进协会 | 作为血管内皮生长因子受体的f1k-1 |
| JP3734262B2 (ja) | 1993-03-25 | 2006-01-11 | メルク エンド カンパニー インコーポレーテッド | 血管内皮細胞増殖因子阻害剤 |
| US6100071A (en) | 1996-05-07 | 2000-08-08 | Genentech, Inc. | Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production |
| US6080728A (en) | 1996-07-16 | 2000-06-27 | Mixson; A. James | Carrier: DNA complexes containing DNA encoding anti-angiogenic peptides and their use in gene therapy |
| DE19638745C2 (de) | 1996-09-11 | 2001-05-10 | Schering Ag | Monoklonale Antikörper gegen die extrazelluläre Domäne des menschlichen VEGF - Rezeptorproteins (KDR) |
| US6348333B1 (en) | 1997-01-17 | 2002-02-19 | Toa Gosei Co., Ltd. | VEGF-binding KDR polypeptide |
| JP4405597B2 (ja) | 1997-06-18 | 2010-01-27 | メルク エンド カムパニー インコーポレーテッド | ヒト受容体型チロシンキナーゼｋｄｒ |
| AU2299099A (en) | 1998-02-04 | 1999-08-23 | Kyowa Hakko Kogyo Co. Ltd. | Antibodies against human vegf receptor kdr |
| GB9804121D0 (en) | 1998-02-26 | 1998-04-22 | Cancer Res Campaign Tech | Anti-angiogenic vaccines: materials and methods relating thereto |
| CA2328893A1 (en) | 1998-05-20 | 1999-11-25 | Kyowa Hakko Kogyo Co., Ltd. | Vegf activity inhibitors |
| WO2001012809A2 (en) | 1999-08-13 | 2001-02-22 | Crucell Holland B.V. | Heterodimeric vegf variants used for inhibiting angiogenesis |
| US7264810B2 (en) | 2001-01-19 | 2007-09-04 | Cytos Biotechnology Ag | Molecular antigen array |
| AU2002362461A1 (en) | 2001-10-01 | 2003-04-14 | Targesome, Inc. | Targeted therapeutic lipid constructs having cell surface targets |
| CU23178A1 (es) | 2002-04-15 | 2006-09-22 | Ct Ingenieria Genetica Biotech | INMUNOTERAPIA ACTIVA ANTIANGIOGéNICA |
| EP2267023B1 (en) | 2002-09-12 | 2015-02-11 | Oncotherapy Science, Inc. | KDR peptides and vaccines comprising the same |
| SI1539157T1 (sl) | 2002-09-18 | 2013-11-29 | Trustees Of The University Of Pennsylvania | Rapamicin za uporabo pri inhibiciji ali preprečevanju horoidalne neovaskularizacije |
| ES2687645T3 (es) | 2003-10-27 | 2018-10-26 | Merck Sharp & Dohme Corp. | Método de diseño de ARNip para el silenciamiento de genes |
| JP2006215988A (ja) * | 2005-02-07 | 2006-08-17 | Ntt Docomo Kansai Inc | 認証システム、携帯端末装置及び認証方法 |
| EP2289532A1 (en) | 2005-02-28 | 2011-03-02 | Oncotherapy Science, Inc. | Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides |
| US20060234941A1 (en) | 2005-04-15 | 2006-10-19 | The Gov. Of The Usa As Represented By The Secretary Of The Dept. Of Health & Human Services | Peptide epitopes of VEGFR-2/KDR that inhibit angiogenesis |
| JP2006315988A (ja) | 2005-05-11 | 2006-11-24 | Mototake Shimizu | ケモカイン産生誘導効果を有する血管新生阻害物質 |
| ES2405763T3 (es) | 2007-02-16 | 2013-06-03 | Oncotherapy Science, Inc. | Vacunoterapia para la neovascularización coroidea |
| JP5272134B2 (ja) | 2007-06-14 | 2013-08-28 | オンコセラピー・サイエンス株式会社 | Ｓｍｙｄ３によるｖｅｇｆｒ１のメチル化調整因子を同定する方法 |
| TWI436775B (zh) * | 2007-08-24 | 2014-05-11 | Oncotherapy Science Inc | 以抗原胜肽合併化療藥劑治療胰臟癌 |
-
2010
- 2010-06-08 TW TW099118513A patent/TW201109029A/zh unknown
- 2010-06-10 WO PCT/JP2010/003871 patent/WO2010143435A1/en not_active Ceased
- 2010-06-10 MX MX2011012659A patent/MX2011012659A/es active IP Right Grant
- 2010-06-10 EP EP10785967.0A patent/EP2440226A4/en not_active Withdrawn
- 2010-06-10 AU AU2010259797A patent/AU2010259797B2/en not_active Expired - Fee Related
- 2010-06-10 CA CA2764562A patent/CA2764562A1/en not_active Abandoned
- 2010-06-10 RU RU2012100241/15A patent/RU2555345C2/ru not_active IP Right Cessation
- 2010-06-10 SG SG10201403109VA patent/SG10201403109VA/en unknown
- 2010-06-10 CN CN2010800356548A patent/CN102802654A/zh active Pending
- 2010-06-10 BR BRPI1013025A patent/BRPI1013025A2/pt not_active IP Right Cessation
- 2010-06-10 SG SG2011090933A patent/SG176737A1/en unknown
- 2010-06-10 KR KR1020117031702A patent/KR20120038419A/ko not_active Withdrawn
- 2010-06-10 US US13/377,110 patent/US8975229B2/en not_active Expired - Fee Related
- 2010-06-10 JP JP2011552249A patent/JP5688587B2/ja not_active Expired - Fee Related
-
2011
- 2011-11-17 IL IL216402A patent/IL216402A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012500001A5 (enExample) | ||
| JP6585720B2 (ja) | 眼疾患治療のペプチド及びこれを含む眼疾患治療用組成物 | |
| JP2022513223A5 (enExample) | ||
| CN105939723B (zh) | 前列腺癌治疗用组合物 | |
| JP2014521684A5 (enExample) | ||
| JP2015522576A5 (enExample) | ||
| AU2018269304B2 (en) | Preparation of biologically active complexes | |
| CN104619727A (zh) | 靶向治疗 | |
| JP2002514658A (ja) | β−アミロイド前駆体タンパク質およびユビキチンＢのフレームシフト変異体ならびにその使用 | |
| CN106232616A (zh) | 两亲性合成抗菌肽、其药物组合物及其用途 | |
| RS61230B1 (sr) | Lečenje neuroloških bolesti | |
| JP2016536369A5 (enExample) | ||
| JP2016510728A5 (enExample) | ||
| JP2014506450A5 (enExample) | ||
| JP2015504052A5 (enExample) | ||
| JP2019535651A5 (enExample) | ||
| JP2006506942A5 (enExample) | ||
| CN110945010A (zh) | 肽组合物和相关方法 | |
| CN120981479A (zh) | Gip/glp1/gcg三受体激动剂及其用途 | |
| HRP20140886T1 (hr) | MUTANTI CyaA POLIPEPTIDI I POLIPEPTIDNI DERIVATI PRIKLADNI ZA DOPREMANJE IMUNOGENIÄŚNIH MOLEKULA U STANICU | |
| RU2012100241A (ru) | Лечение хориоидальной неоваскуляризации с помощью вакцин | |
| US12552848B2 (en) | Hydrochloride salts of C5a receptor agonist peptides | |
| RU2013103487A (ru) | Вакцинотерапия неоваскуляризации сосудистой оболочки глаза | |
| JP2008531463A5 (enExample) | ||
| JP2019519466A5 (enExample) |